From Medscape Gastroenterology
A National Strategy for Viral Hepatitis Control: AASLD 2010
Robert G. Gish, MD
Authors and Disclosures
Posted: 11/12/2010
Watch Video
Hello, I'm Robert Gish. I will be starting as Chief of Hepatology at the University of California, San Diego, in San Diego, California, on December 1, as well as being Medical Director, Center for Hepatobiliary Disease and Abdominal Transplantation.
I'm here at the AASLD [American Association for the Study of Liver Diseases] 2010 in Boston, and I'd like to comment on this year's President's Choice lecture[1] for Medscape. This lecture focused on the findings of the Institute of Medicine study, Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C.[2]
What are the findings and what are the clinical implications for hepatitis B and C?
Watch Video
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment